LEVIN JEREMY M [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
02/23/2023	Ovid Therapeutics Inc.	OVID	Grant	Stock Option (Right to Buy)	600k	$2.50	$1.5M		02/23/2023
04/08/2022	Ovid Therapeutics Inc.	OVID	Grant	Stock Option (Right to Buy)	423.2k	$3.22	$1.4M		04/08/2022
02/03/2022	Ovid Therapeutics Inc.	OVID	Grant	Stock Option (Right to Buy)	600k	$2.72	$1.6M		02/03/2022
12/17/2020	Ovid Therapeutics Inc.	OVID	Grant	Stock Option (Right to Buy)	650k	$2.82	$1.8M		12/17/2020
08/28/2020	Ovid Therapeutics Inc.	OVID	Purchase	Common Stock	8.5k	$5.84	$49.6k		08/28/2020
12/18/2019	Ovid Therapeutics Inc.	OVID	Grant	Stock Option (Right to Buy)	600k	$4.42	$2.7M		12/18/2019
10/08/2019	Ovid Therapeutics Inc.	OVID	Purchase	Common Stock	60k	$2.50	$150k		10/08/2019
02/24/2019	Ovid Therapeutics Inc.	OVID	Grant	Employee Stock Option (Right to Buy)	250k	$1.89	$472.5k		02/22/2019
02/22/2019	Ovid Therapeutics Inc.	OVID	Purchase	Common Stock	75k	$2.00	$150k		02/22/2019
01/19/2018	Ovid Therapeutics Inc.	OVID	Grant	Employee Stock Option (Right to Buy)	290k	$9.18	$2.7M		01/19/2018
08/25/2017	Ovid Therapeutics Inc.	OVID	Purchase	Common Stock	15.3k	$7.15	$109.6k		08/25/2017
05/10/2017	Ovid Therapeutics Inc.	OVID	Conversion	Common Stock	400.2k	$0.00	$0		05/10/2017
05/10/2017	Ovid Therapeutics Inc.	OVID	Conversion	Common Stock	35.5k	$0.00	$0	See Footnote	05/10/2017
05/10/2017	Ovid Therapeutics Inc.	OVID	Conversion	Series A Preferred Stock	400.2k	$0.00	$0		05/10/2017
05/10/2017	Ovid Therapeutics Inc.	OVID	Conversion	Series B Preferred Stock	35.5k	$0.00	$0	See Footnote	05/10/2017
03/01/2011	BRISTOL MYERS SQUIBB CO	BMY	Payment of Exercise	Common Stock, $0.10 par value	2.3k	$25.58	$59.4k		03/01/2011
03/01/2011	BRISTOL MYERS SQUIBB CO	BMY	Payment of Exercise	Common Stock, $0.10 par value	2.9k	$25.58	$74.6k		03/01/2011